Kintara Therapeutics News

8-K: Current report

Apr 25 09:09 ET

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Apr 25 09:09 ET

Kintara Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Apr 3 07:17 ET

Kintara Therapeutics | 8-K: Current report

Apr 3 07:12 ET

Kintara Therapeutics | RW: Registration Withdrawal Request

Mar 13 07:03 ET

Kintara Therapeutics | 8-K: Current report

Feb 27 07:05 ET

Kintara Therapeutics | 8-K: Current report

Feb 26 07:05 ET

Kintara Therapeutics | 8-K: Current report

Feb 22 07:01 ET

Kintara Therapeutics | 8-K: Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update

Feb 14 17:57 ET

Kintara Therapeutics | 10-Q: Quarterly report

Feb 14 16:15 ET

Kintara Therapeutics | 8-K: Current report

Feb 12 09:09 ET

Kintara Therapeutics | 8-K: Current report

Dec 18, 2023 16:10 ET

Kintara Therapeutics | 424B5: Prospectus

Dec 18, 2023 16:05 ET

Kintara Therapeutics | 8-K: Current report

Dec 15, 2023 16:15 ET

Kintara Therapeutics | 8-K: Current report

Dec 7, 2023 09:10 ET

Kintara Therapeutics | 8-K: Current report

Dec 5, 2023 09:10 ET

Kintara Therapeutics | 8-K: Current report

Nov 21, 2023 07:55 ET

Kintara Therapeutics | 8-K: Kintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate Update

Nov 13, 2023 16:15 ET

Kintara Therapeutics: Q1 2024 Earnings Report

Nov 13, 2023 16:05 ET

Kintara Therapeutics | 8-K: Current report

Oct 31, 2023 08:10 ET